Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Humacyte, Inc
Humacyte to Host Virtual KOL Event to Discuss ATEV for Arteriovenous (AV) Access for Hemodialysis Patients on April 28, 2026
May 26, 2026
Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess®
May 26, 2026
Humacyte Appoints Jim Mercadante as Chief Commercial Officer
May 26, 2026
Humacyte Announces Israeli Ministry of Health Acceptance of Marketing Authorization Application for Symvess® for Vascular Trauma Repair
May 26, 2026
Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update
May 22, 2026
Humacyte Appoints Rick McElheny as Senior Vice President of Business Development
May 22, 2026
Humacyte To Announce 2025 Fourth Quarter and Year End Financial Results and Provide Business Update on March 27, 2026
May 22, 2026
Humacyte Receives Symvess® Purchase Commitment for Clinical Evaluation and Outreach Program in the Kingdom of Saudi Arabia
May 20, 2026
Humacyte, Inc. Announces Pricing of $20 Million Registered Direct Offering of Common Stock
May 20, 2026
Humacyte Submits Marketing Authorization Application for Symvess® in Israel for Vascular Trauma Repair
May 20, 2026